---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-019779"
form_type: "8-K"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:15:20.626995+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Wellgistics Health partners with DataVault AI to develop blockchain-based PharmacyChain for prescription drug tracking

## Summary
- SaaS agreement with DataVault AI (NASDAQ: DVLT) to develop PharmacyChain, a manufacturer-to-patient blockchain platform.
- Beta testing expected in first half of 2026; profit-sharing license agreement to be finalized in Q4 2025.
- Platform aims to improve prescription tracking, insurance reimbursement, and patient adherence in $639B prescription drug market.
- DataVault AI's patents cover blockchain data scoring, valuation, and monetization; platform to enable secure data transfer for pharmacists.
- Wellgistics expects PharmacyChain to drive market share gains and expansion into new markets.

## SEC filing metadata
- accession: 0001493152-25-019779
- form_type: 8-K
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000149315225019779/0001493152-25-019779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000149315225019779/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-019779
- JSON: https://secwatch.observer/filing/0001493152-25-019779.json
- Plain text: https://secwatch.observer/filing/0001493152-25-019779.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.